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Background: Relative accuracy of the various currently available cardiovascular (CV) risk
assessment algorithms in Indian patients is not known.
Methods: This study included 194 consecutive patients (mean age 49.6 ± 10.3 years, 84.5%
males) attending a CV disease prevention clinic at a tertiary center in north India. Four risk
assessment models [Framingham Risk score (RiskFRS), American College of Cardiology/
American Heart Association pooled cohort equations (RiskACC/AHA), the 3rd iteration of Joint
British Societies' risk calculator (RiskJBS) and the World Health Organization/International
Society of Hypertension risk prediction charts (RiskWHO)] were applied. The estimated risk
scores were correlated with carotid intima-media thickness (CIMT) and coronary calcium
score (CCS) using nonparametric statistics (Chi-square test, KruskaleWallis test and
Spearman rank correlation).
Results: Overall, RiskACC/AHA and RiskWHO significantly underestimated CV risk as compared
to RiskJBS and RiskFRS, with RiskJBS being the least likely to underestimate the risk (patients
with coronary artery disease who were found to have 20% CV risk- 21.4% with RiskACC/
AHA, 17.9% with RiskWHO, 41.4% with RiskFRS, and 58.6% with RiskJBS). Further, only RiskJBS
and RiskFRS, but not RiskACC/AHA and RiskWHO, demonstrated consistent relationship with
CIMT and CCS (Spearman rho 0.45 and 0.46 for RiskJBS and 0.39 and 0.36 for RiskFRS for CIMT
and CCS respectively, all p values < 0.001).
Conclusions: The present study shows that in Indian subjects RiskJBS appears to provide the
most accurate estimation of CV risk. It least underestimates the risk and has the best
correlation with CIMT and CCS. However, large-scale prospective studies are needed to
confirm these findings.
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Estimation of the risk of future atherosclerotic cardiovascular
(CV) events is an important step in the management of the
patients requiring primary prevention of CV disease. The
ability to quantify CV risk allows objective assessment of the
‘seriousness’ of the illness, provides ameans to communicate
the same to the patient and his family, and most importantly,
forms the basis on which a number of important therapeutic
decisions are taken.1,2
A number of CV risk scoring systems are currently avail-
able for use in different population groups, such as Framing-
ham risk score (RiskFRS),
3,4 Prospective Cardiovascular
Munster Score (PROCAM),5 Systemic Coronary Risk Evaluation
(SCORE),6 World Health Organization/International Society of
Hypertension (WHO/ISH) CV disease risk prediction charts
(RiskWHO)
7 and themore recently developed American College
of Cardiology/American Heart Association (ACC/AHA) pooled
cohort equations (RiskACC/AHA)
8 and the 3rd iteration of Joint
British Societies' risk calculator (RiskJBS).
9 However, as these
risk algorithms are based on epidemiological data, they are
applicable only to those populations from which the data has
been derived. Unfortunately, none of the currently available
risk prediction models is based on Indian data or has been
prospectively validated in Indians. Although a few studies
have attempted to evaluate the relative accuracy of these
western CV risk scores in Indians, the evidence remains
grossly limited.10,11 We, therefore, sought this study to
compare the accuracy of four clinically relevant CV risk
assessment algorithms- RiskFRS, RiskJBS, RiskACC/AHA abd
RiskWHO- in a north Indian population. The risk estimates
derived using these four algorithms were correlated with ca-
rotid intima-media thickness (CIMT) and coronary calcium
score (CCS)- the two well established measures of subclinical
atherosclerosis and reliable predictors of future risk of CV
events.2. Methods
This cross-sectional study included consecutive subjects
attending a CV disease prevention clinic at a tertiary care
center in north India. The subjects were eligible to be included
in the present study if they-
 were 30 years of age,
 had undergone computed tomographic (CT) coronary
angiography along with CCS estimation,
 did not have previously known coronary artery disease
(CAD), and
 did not have any other concomitant major cardiac illness.
Thus, a total of 194 subjects were included in the study. All
subjects underwent clinical evaluation, biochemical in-
vestigations and measurement of CIMT. In addition, as
mentioned above, all subjects had already undergone CCS
estimation.
The clinical evaluation included history regarding the
presence or absence of CV risk factors, duration of CV riskfactors, symptoms suggestive of CAD etc. Physical examina-
tion included height, weight & blood pressure (BP) measure-
ment and the examination of CV system. BP was measured in
the right arm in supine position, using a standard sphygmo-
manometer. Biochemical investigations included a fasting
lipid profile and fasting & 2-h post-prandial blood glucose
estimation.
For the purpose of the present study, hypertension was
defined according to Joint National Committee (JNC) 7 guide-
lines as systolic BP 140mmHg or diastolic BP 90mmHg or
previous history of hypertension or self reported use of anti-
hypertensive medications.12 Diabetes mellitus was defined
as fasting blood glucose 126 mg/dl or 2-h postprandial blood
glucose200mg/dl or pharmacological treatment for diabetes
or previous history of diabetes mellitus. Family history was
considered positive if a coronary event had occurred in amale
first degree relative before the age of 55 years or a female first
degree relative before the age of 65 years. Smoking or tobacco
use in any form during the preceding month was also
considered to be a CV risk factor.
2.1. Estimation of CV risk
Based on the information collected, 10-year risk of having a
major CV event [CV death,myocardial infarction (MI) or stroke]
was calculated for each patient using RiskFRS, RiskJBS, RiskACC/
AHA and RiskWHO. However, as RiskACC/AHA and RiskWHO limit
10-year risk estimation only to the individuals 40 years of
age, those <40 years of age (n ¼ 37) were excluded when
calculating 10-year risk estimates using these two algorithms.
Similarly, RiskFRS could not be applied in 2 patients as they
were >74 years of age and RiskJBS could not be applied in 3
patients because their body-mass index values were not
available.
RiskFRS and the RiskACC/AHA calculators are available for
download from the websites https://www.framingham
heartstudy.org/risk-functions/cardiovascular-disease/10-year-
risk.php# and http://my.americanheart.org/professional/
StatementsGuidelines/Prevention-Guidelines_UCM_457698_
SubHomePage.jsp respectively. RiskJBS is available as an online
calculator at www.jbs3risk.com. The WHO/ISH risk prediction
charts are included as part of the ‘Guideline for assessment
and management of cardiovascular risk’ available at the WHO
website (http://www.who.int/cardiovascular_diseases/publica
tions/Prevention_of_Cardiovascular_Disease/en/). The chart
applicable for South-East Asian region D (which includes
Bangladesh, Bhutan, Democratic People's Republic of Korea,
India, Maldives, Myanmar and Nepal) was used in the present
study.
Using these risk assessment models, 10-year absolute CV
risk estimates were derived and divided in to the following
three categories e <10%, 10e19.9% and 20%. RiskWHO, how-
ever, only provides range estimates and not the absolute risk
estimates.
2.2. CIMT assessment
CIMT measurement was performed following the standard
protocol.13 Distal common carotid artery (CCA) was imaged
on both sides with a 7.5 MHz frequency linear array
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machine. The artery was imaged in a longitudinal plane to
obtain optimal angle of incidence, defined as the plane in
which the bifurcation of the carotid bulb into the internal and
external carotid arteries can be visualized simultaneously
with the bulb and distal CCA (also known as ‘tuning fork’
view). Once this view was obtained, finer adjustments in the
transducer position were done to ensure distal CCA was
perfectly horizontal on the screen and ‘double lines’ of in-
tima and adventitia were clearly visualized in the far wall of
the CCA (‘double-line’ sign). From this view, CIMT was
measured as the distance between the lumen-intima inter-
face and the media-adventitia interface. Plaques, defined as
50% localized thickening of the intima compared to the rest
of the wall, were included in the measurement of CIMT if
present within the distal 1 cm of CCA.
The CCA was then imaged from two additional compli-
mentary angles, approximately 45 anterior and posterior to
the first image and the CIMT measurement was performed.
The six values thus obtained (three for each side) were aver-
aged and used for analysis.
Reproducibility of CIMT measurement in our lab has
already been documented previously.14
2.3. Coronary calcium scoring
Multi-detector CT of the heart was performed using dual
source dual energy Somatom Definition Flash (Siemens
Healthcare, Germany) with 128 0.6mm collimation, rotation
time 75 ms and tube voltage of 80 & 140 kV. In a single breath-
hold, images were acquired from the level of tracheal bifur-
cation to the base of the heart using prospective ECG-
triggering with the centre of the acquisition at 70% of the
ReR interval. From the raw data, the images were recon-
structed with standard kernel in 3 mm thick axial, non-
overlapping slices and 25 cm field of view. All image ana-
lyses were performed on a dedicated workstation (MMWP and
Syngovia Siemens, Germany). A coronary calcified lesion was
defined as an area with a density >130 Hounsfield units and
covering at least 6 pixels. The Agatston method was used to
determine the coronary calcium score (CCS) by multiplying
each lesion area by a weighted CT attenuation score in the
lesion.153. Statsitical analysis
The data were managed on Microsoft excel spreadsheet
(version 2007, Microsoft Corp, Seattle, Washington) and
analyzed using SPSS for Windows (release 15.0, SPSS Inc,
Chicago, IL, USA). Standard descriptive analysis was per-
formed. The categorical variables were expressed as actual
numbers with percentages and the continuous variables as
mean ± standard deviation (for normally distributed data) or
as median with interquartile ranges (for CIMT and CCS, which
were not normally distributed). The comparisons among
different risk groups and disease groups were performed
using Chi-square test for categorical variables and one-way
analysis of variance or KruskaleWallis test, as appropriate,
for continuous variables. Spearman rho (r) was estimated toassess the relationship between various risk estimates and
the measures of subclinical atherosclerosis. A p value <0.05
was considered statistically significant.4. Results
A total of 194 subjects were included in the study. The mean
age of the study subjects was 49.6 ± 10.3 years and 164
(84.5%) were males. Nearly two-thirds (67.5%) had hyper-
tension, one third (32.0%) had diabetes and another third
(30.9%) were smokers. The mean body-mass index was
28.4 ± 4.2 kg/m2.4.1. CT angiographic extent of CAD and its relationship
with CV risk factors and risk estimates (Tables 1 and 2)
For the purpose of analysis, the study population was divided
in to 3 groups based on CT coronary angiography findings-
B No CAD group (n ¼ 117)- normal coronaries
B Non-critical CAD group (47)- those with <50% stenotic
plaque(s) in any one or more of the major epicardial coro-
nary arteries or their major branches
B CAD group (n ¼ 30)- those who had 50% stenotic lesion(s)
in any one or more of the major epicardial coronary ar-
teries or their major branches
The patients with CAD were older (p < 0.001) and were
more likely to be smokers (p 0.04) than the other two groups
(Table 1) whereas total cholesterol and low-density lipo-
protein cholesterol were higher in those with normal coro-
nary arteries (p values 0.03 and 0.047, respectively).The 10-
year CV risk estimates derived using all the risk scores
showed progressive increase with increasing extent of CAD.
However, RiskACC/AHA and RiskWHO provided lower risk es-
timates as compared to RiskFRS and RiskJBS. Moreover, using
the traditional threshold of 20% 10-year risk to define high
CV risk, only RiskFRS and RiskJBS could adequately discrimi-
nate among different CAD categories (p values 0.014
and < 0.001, respectively; Table 2). RiskACC/AHA and RiskWHO
significantly underestimated CV risk with only 21.4% and
17.9% of those in the CAD group found to have 20% CV risk
using these risk algorithms. In comparison, RiskFRS identi-
fied 41.4% and RiskJBS 58.6% of these patients as at ‘high CV
risk’.4.2. CT angiographic extent of CAD and its relationship
with CIMT and CCS
Both CIMT and CCS progressively increased as the CT angio-
graphic extent of CAD increased (p value 0.004 for CIMT and
<0.001 for CCS; Table 2). In addition, zero calcium score was
seen in 79.5% of the patients with normal coronaries but only
16.7% of those with CAD (p < 0.001). These findings reinforce
the validity of CIMT and CCS as surrogate measures of
atherosclerosis.
Table 1 e Clinical and biochemical characteristics of the study population according to presence or absence of coronary
artery disease.
Parameter No CAD (n ¼ 117) Non-critical CAD (n ¼ 47) CAD (n ¼ 30) p Value
Age (years) 46.2 ± 9.3 54.7 ± 9.7 54.9 ± 9.5 <0.001
Male gender, n (%) 97 (82.9) 40 (85.1) 27 (90.0) 0.63
Hypertension, n (%) 75 (64.1) 32 (68.1) 24 (80.0) 0.25
Diabetes mellitus, n (%) 33 (28.2) 19 (40.4) 10 (33.3) 0.31
Current smokers, n (%) 39 (33.3) 8 (17.0) 13 (43.3) 0.04
Body mass index (kg/m2) 28.5 ± 4.1 28.1 ± 3.5 28.7 ± 5.8 0.81
Systolic blood pressure (mmHg) 132.1 ± 18.5 133.0 ± 15.4 132.2 ± 13.1 0.95
Diastolic blood pressure (mmHg) 81.9 ± 9.6 81.7 ± 9.3 83.0 ± 8.2 0.80
Fasting blood glucose (mg/dL) 105.7 ± 24.3 121.5 ± 43.1 109.0 ± 26.3 0.03
Total cholesterol (mg/dL) 192.5 ± 47.7 173.1 ± 39.2 179.3 ± 39.0 0.03
Serum triglycerides (mg/dL) 164.2 ± 97.4 134.4 ± 55.2 149.2 ± 92.6 0.15
HDL-cholesterol (mg/dL) 42.3 ± 12.1 43.4 ± 12.2 43.3 ± 11.7 0.83
LDL-cholesterol (mg/dL) 117.5 ± 43.3 100.8 ± 38.5 107.0 ± 31.1 0.047
*All values are mean ± standard deviation or actual number with percentages in parentheses.
CAD, coronary artery disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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and CCS (Table 3, Figs. 1 and 2)
Correlations between CIMT and CCS and the absolute CV risk
estimates derived using RiskFRS, RiskJBS and RiskACC/AHA were
assessed using Spearman rank correlation (a similar analysis
could not be performed for RiskWHO because it only provided
risk ranges and not the absolute risk estimates). Statistically
significant correlations were found between CIMT and CCS
and all the three scoring systems (RiskFRS- r 0.39 and 0.36, both
p values <0.001; RiskJBS- r 0.45 and 0.46, both p values <0.001;
and RiskACC/AHA- r 0.38 and 0.27, p values <0.001 and 0.001,
respectively) (Fig. 1). However, as evident, RiskJBS demon-
strated stronger relationship as compared to the other two
risk scores, whereas RiskACC/AHA had the weakest relationshipTable 2 e Estimated cardiovascular risk and measures of subc
coronary artery disease.
Parameter No CAD (n ¼ 117)
Framingham risk score (n ¼ 192)
 Mean score ± std dev 13.0 ± 9.4
 Patients with 20% 10-year risk, n (%) 23/117 (19.7)
JBS3 risk score (n ¼ 191)
 Mean score ± std dev 12.2 ± 11.2
 Patients with 20% 10-year risk, n (%) 23/116 (19.8)
ACC/AHA risk score (n ¼ 157)
 Mean score ± std dev 7.8 ± 7.7
 Patients with 20% 10-year risk, n (%) 7/86 (8.1)
WHO/ISH risk score (n ¼ 157)
 Patients with 20% 10-year risk, n (%) 11/86 (12.8)
Carotid intima-media thickness (mm)
 Median (interquartile range) 0.60 (0.5, 0.79)
Coronary calcium score
 Median (interquartile range) 0 (0, 0)
 Calcium score categories-
‘0’ score, n (%) 93 (79.5)
1e99, n (%) 23 (19.7)
100e399, n (%) 1 (0.9)
400, n (%) 0 (0)
ACC, American College of Cardiology; AHA, American Heart Association
Societies.(esp. with CCS). When the study subjects were categorized
into various risk categories based on their 10-year CV risk
estimates (i.e. <10%, 10e19.9% and 20%), there was pro-
gressive increase in CIMT and CCS with increasing risk cate-
gories based on RiskFRS and RiskJBS, with RiskJBS demonstrating
stronger relationship as compared to RiskFRS. In contrast,
RiskACC/AHA and RiskWHO showed a relationship only with
CIMT and not with CCS (Fig. 2, Table 3).5. Discussion
The salient findings of the present study are - 1) RiskACC/AHA
and RiskWHO significantly underestimate CV risk in Indian
patients. RiskJBS and RiskFRS are more accurate, with RiskJBSlinical atherosclerosis according to presence or absence of
Non-critical CAD (n ¼ 47) CAD (n ¼ 30) p Value
17.7 ± 10.1 20.0 ± 9.5 <0.001
17/46 (37.0) 12/29 (41.4) 0.014
18.3 ± 12.5 24.3 ± 13.7 <0.001
14/46 (30.4) 17/29 (58.6) <0.001
11.7 ± 10.9 12.1 ± 7.7 0.02
7/43 (16.3) 6/28 (21.4) 0.13
6/43 (14.0) 5/28 (17.9) 0.80
0.75 (0.60, 0.80) 0.75 (0.65, 0.90) 0.004
18.1 (1.0, 63.2) 67.1 (21.2, 268.5) <0.001
10 (21.3) 5 (16.7)
31 (66.0) 12 (40.0) <0.001
5 (10.6) 9 (30.0)
1 (2.1) 4 (13.3)
; CAD, coronary artery disease; JBS3, 3rd iteration of the Joint British
Table 3 e Carotid intima-media thickness and coronary calcium scores according to the estimated cardiovascular risk
categories.
Risk algorithm 10-year risk categories Carotid intima-media thickness (mm) Coronary calcium score
Median (interquartile range) p Value Median (interquartile range) p Value
Framingham risk score <20% (n ¼ 140) 0.60 (0.55, 0.76) 0.002 0 (0, 18.8) 0.008
20% (n ¼ 52) 0.74 (0.60, 0.90) 7.5 (0, 64.1)
JBS3 risk score <20% (n ¼ 137) 0.60 (0.55, 0.75) <0.001 0 (0, 12.5) <0.001
20% (n ¼ 54) 0.80 (0.65, 0.90) 21.4 (0, 127.5)
ACC/AHA risk score <20% (n ¼ 137) 0.65 (0.60, 0.80) 0.02 0.2 (0, 48.6) 0.13
20% (n ¼ 20) 0.85 (0.64, 1.0) 16.6 (0, 208.2)
WHO/ISH risk score <20% (n ¼ 135) 0.65 (0.60, 0.80) 0.004 0.7 (0, 58.1) 0.90
20% (n ¼ 22) 0.90 (0.65, 1.00) 1.1 (0, 68.1)
ACC, American College of Cardiology; AHA, American Heart Association; JBS3, 3rd iteration of the Joint British Societies.
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and RiskFRS, but not RiskACC/AHA and RiskWHO, demonstrate
consistent relationship with the measures of subclinical
atherosclerosis (i.e. CIMT and CCS). The strength of the asso-
ciation appears to be stronger for RiskJBS than the same for
RiskFRS.
5.1. CV risk estimation in Indians
In the current era of evidence-based medicine, all our de-
cisions need to be based on robust scientific evidence. The
current guidelines recommend that the use of statins and
aspirin should be linked to the anticipated CV risk in the given
individual. Hence, it is essential to assess CV risk in every
patient in whom a statin or aspirin is prescribed for primary
prevention of CV disease. The estimation of CV risk has an
added advantage that it provides an objective measure of the
‘seriousness’ of the illness and may help improve patient
compliance to the treatment.
The major challenge to CV risk estimation in Indian pa-
tients is the lack of a prospectively validated, ethnic specific
CV risk assessment algorithm for Indian population. As In-
dians are known to have considerable differences in the CV
disease epidemiology as compared to the western pop-
ulations,16e22 the risk scoring systems based on the western
data may not be directly applicable to them. Consistent with
this, several previous studies have shown that the currently
available western risk assessment models tend to underesti-
mate the risk in South Asians, including Indians.17,20,21,23,24
Several different approaches have been tried to overcome
this challenge. Chow et al utilized data derived as part of the
Andhra Pradesh Rural Health Initiative and demonstrated that
it was feasible to recalibrate RiskFRS to render it applicable to a
given ethnic/regional group.25 However, the study also
showed that reliable local CV epidemiology data was required
to achieve accurate recalibration of RiskFRS.
An alternate approach is to apply multiple scoring systems
in the same population group and compare their accuracy to
determine which one is likely to be more accurate. As an
example, Kanjilal et al10 compared 3 different risk scoring
systems- RiskFRS, SCORE and an older version of JBS risk score
in the family members of the patients with CV disease. It was
found that despite significantly elevated levels of lipids, pro-
inflammatory, pro-thrombotic, and serological markers, all 3risk scores identified <5% population as being at ‘high-risk’. In
a more recent study involving patients presenting with acute
MI, we compared the same four risk scores as evaluated in the
present study.11 It was found that RiskJBS was the most likely
to correctly identify these individuals as ‘at high-risk’whereas
RiskWHO most underestimated the risk. However, a major
limitation of this study was that retrospective risk estimation
was performed in patients who had already presented with a
major CV event.
Therefore, in the present study, we included out-patients
undergoing primary or secondary prevention of CV disease.
Once again, we found that RiskJBS had the best accuracy for
assessing atherosclerosis burden. In comparison, RiskFRS had
lower, albeit comparable, accuracy whereas RiskACC/AHA and
RiskWHO were much inferior. These two studies together
provide the evidence to support that RiskJBS is perhaps the
most suited CV risk assessment tool for use in Indians at
present.
There could be several explanations why RiskJBS was found
to be more accurate in our study. First, RiskJBS is the only risk
assessment model that includes data derived from ethnic
Indians, even though non-resident ones. Second, RiskJBS is a
more comprehensive risk assessment model and takes in to
account several additional risk factors such as obesity and
family history of premature CV disease. Inclusion of these risk
factors is likely to enhance the accuracy of risk prediction.5.2. CIMT and CCS as surrogate measures of subclinical
atherosclerosis
CIMT and CCS are established measures of subclinical
atherosclerosis and are being widely used in epidemiological
studies as well as in research on atherosclerosis.13,26e34
Numerous studies have demonstrated that both CIMT and
CCS are excellent predictors of future CV risk and have in-
cremental predictive value over conventional risk factors and
risk assessment algorithms.13,26e28,30e32,34 Several studies
performed in Indian subjects have also documented that CIMT
and CCS are associated with the presence of CV risk factors
and CV disease.33,35e42 In the present study also, CIMT and
CCS correlatedwith the extent of coronary disease as assessed
by CT coronary angiography, which further reinforces their
value as reliable measures of atherosclerotic vascular disease.
Fig. 1 e Correlations between the 10-year cardiovascular risk estimates derived using various risk scores and carotid
intima-media thickness (left-side panels) and coronary calcium score (right-side panels). A, B- Framingham risk score; C, D-
3rd Iteration of the Joint British Societies (JBS3) risk score; and E, F- American College of Cardiology/American Heart
Association (ACC/AHA) risk score.
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atherosclerosis, CCS appears to be the most robust.29,34,43 It
has been shown to have excellent accuracy to predict risk of
adverse CV outcomes in a wide-variety of clinical settings,
including asymptomatic patients with CV risk factors, pa-
tients with stable CAD as well as those presenting with an
acute coronary event.29,346. Limitations
The main limitations of our study were its cross-sectional
nature and the small sample size. As the clinical risk algo-
rithms are meant only for estimating future risk of CV events,
the only appropriate method to test their accuracy is to
Fig. 2 e Median values of carotid intima-media thickness
(upper panel) and coronary calcium scores (lower panel)
according to the estimated 10-year cardiovascular risk
categories. ACC, American College of Cardiology; AHA,
American Heart Association; ISH, International Society of
Hypertension; JBS3, 3rd iteration of the Joint British
Societies, WHO, World Health Organization.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 3 3 2e3 4 0338conduct a large-scale prospective study. While the need to
have a large-scale prospective study cannot be over-
emphasized, performing such a studymay not be feasible due
to the obvious logistic constraints, particularly in a country
like ours. Given these constraints, our study explores an
alternate strategy to assess predictive accuracy of the
different CV risk assessment algorithms in Indian subjects.
We utilized CIMT and CCS as a surrogate for future risk of CV
events, based on the enormous evidence generated from
large-scale epidemiological studies. However, we do agree
that a larger sample size would have enhanced the validity of
our study findings.
Some of our patients were already on statins and angio-
tensin converting enzyme inhibitors which must have altered
the relationship between various risk scores and CIMT and
CCS. However, it is unlikely to have appreciably affected our
study's main findings. Most of the patients who were on these
therapies were only recently initiated on the treatment.
Although significant lowering of cholesterol values may occur
even with a short course of statin, CIMT and CCS change only
gradually, taking several months to years to demonstrate any
measurable change. Therefore, the use of statins could only
lead to underestimation of CV risk by various risk algorithms,thereby weakening their relationships with CIMT and CCS.
However, as total cholesterol is included in all the four risk
scores evaluated in the present study, it is unlikely that statins
would have differentially affected one risk score more than
the other.
Finally, we only measured CIMT and did not specifically
assess carotid plaques in the present study. The available
evidence suggests that carotid plaques are more predictive of
future CV events as compared to elevated CIMT.44 However,
we had included multiple measures of subclinical athero-
sclerosis, including CCS which has been shown to be more
robust than carotid ultrasound imaging.7. Conclusions
The present study shows that in Indian subjects, RiskFRS and
RiskJBS demonstrate better correlation with various measures
of subclinical atherosclerosis than RiskACC/AHA and RiskWHO.
Further, RiskJBS is the least likely to underestimate CV risk in
these individuals. These findings suggest that RiskJBS may be
the most appropriate CV risk assessment algorithm for use in
Indians at present. However, large-scale prospective studies
are needed to confirm these findings.Conflicts of interest
The authors have none to declare.
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